| Literature DB >> 22827914 |
Ling Zeng, An-qiang Zhang, Wei Gu, Jian Zhou, Lian-yang Zhang, Ding-yuan Du, Mao Zhang, Hai-yan Wang, Jun Yan, Ce Yang, Jian-xin Jiang.
Abstract
INTRODUCTION: The receptor for advanced glycation end products (RAGE) has been considered as one of the major pattern recognition receptors and plays an important role in the development of sepsis and multiple organ dysfunction in critical illnesses. Although genetic variants of the RAGE gene have been shown to be well associated with susceptibility to some inflammatory diseases, little is known about their clinical relevance in the development of sepsis in critical ill patients.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22827914 PMCID: PMC3580716 DOI: 10.1186/cc11436
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
SNPs identified within whole RAGE gene
| rs number | Location | Variation | MAF | Region | |
|---|---|---|---|---|---|
| 1 | rs1800625 | -429 | T/C | 0.122 | promoter |
| 2 | rs1800624 | -374 | T/A | 0.163 | promoter |
| 3 | rs3131300 | 79 | A/G | 0.122 | Intron1 |
| 4 | rs2070600 | 570 | G/A | 0.289 | Exon3 |
| 5 | rs2269422 | 719 | A/G | 0.057 | Intron3 |
| 6 | rs1035798 | 791 | C/T | 0.167 | Intron3 |
| 7 | rs184003 | 1717 | G/T | 0.116 | Intron5 |
| 8 | rs3134940 | 2197 | A/G | 0.11 | Intron7 |
| 9 | rs2853807 | 2441 | C/T | 0.068 | Intron7 |
| 10 | rs2071288 | 2753 | G/A | 0.022 | Intron8 |
| 11 | rs8365 | 3610 | C/G | 0.114 | 3'-flanking |
Genetic variation data for the entire RAGE gene was obtained from the HapMap project for 45 members of the Chinese Han Beijing (CHB) population. MAF, minor allele frequency; SNPs, single nucleotide polymorphisms
Figure 1Overview of selected tSNPs within the entire . (A) The pair-wise analysis of linkage disequilibrium (LD), based on r2, among the 10 SNPs with a minor allele frequency ³5% within the RAGE gene and 505 bp up- and 5,000 bp down-stream regions. The selected tSNPs are indicated by trigones. A LD-plot of the 10 SNPs is displayed by using r2-black and white color scheme. Black represents very high LD (r2 = 0.8-1), and white indicates the absence of correlation (r2 = 0-0.2) between SNPs. (B) The two tSNPs and SNPs that are indirectly measured by them are listed with corresponding r2-values. Major and minor alleles of the selected tSNPs are given with their frequencies, based on the HapMap data for the CHB population.
Overall clinical characteristics of patients with major trauma
| Chongqing (N = 496) | Zhejiang (N = 232) | |
|---|---|---|
| Age (yrs) | 40.4 ± 14.2 (18 to 65) | 41.0 ± 13.1 (18 to 65) |
| Male/female, n | 395/101 | 190/42 |
| Injured body regions, n (%) | ||
| Head, n | 187 (37.7) | 73 (31.5) |
| Thorax, n | 205 (41.3) | 142 (61.2) |
| Abdomen, n | 136 (27.4) | 74 (31.9) |
| Extremities, n | 252 (50.8) | 165 (71.1) |
| Number of regions injured, n (%) | ||
| One, n | 145 (29.2) | 74(31.9) |
| Two, n | 133 (26.8) | 59 (25.4) |
| Three or above, n | 80 (16.1) | 37 (15.9) |
| ISS | 22.0 ± 10.5 | 23.3 ± 8.7 |
| ≥16, <25, n (%) | 301 (60.7) | 131 (56.5) |
| ≥25, n (%) | 195 (39.3) | 101 (43.5) |
| Organ dysfunction, n (%) | ||
| One, n | 132 (26.6) | 76 (32.8) |
| Two, n | 125 (25.2) | 59 (25.4) |
| Three or above, n | 72 (14.5) | 35 (15.1) |
| Sepsis, n (%) | 202 (40.7) | 88 (37.9) |
| Source of infection, % | ||
| Respiratory tract infection | 41.6 | 39.8 |
| Primary bloodstream infection | 21.8 | 23.9 |
| Urinary tract infection | 16.3 | 11.4 |
| Catheter associated infection | 10.9 | 9.1 |
| Wound infection | 7.4 | 9.1 |
| Others* | 2.0 | 6.8 |
| Pathogens, % (positive blood cultures) | ||
| Gram-negative | 21.0 | 24.6 |
| Gram-positive | 18.0 | 15.9 |
| Fungi | 2.2 | 2.2 |
| Mixed Gram negative and positive | 5.8 | 7.3 |
| Negative blood cultures | 53.0 | 50.0 |
Distribution of the four variants in the RAGE gene among trauma patients
| MA (%) | Genotypes, n (%) | HWE | ||||||
|---|---|---|---|---|---|---|---|---|
| SNPs | N | Patients | Databank | wild | Heterozygous | variant | ||
| 63bp ins/del | 496 | 7.7 | 423 (85.3) | 70 (14.1) | 3 (0.6) | 0.96 | ||
| rs2070600 | 496 | 29.4 | 28.9 | 247 (49.8) | 206 (41.5) | 43 (8.7) | 0.99 | |
| rs1800624 | 496 | 14.8 | 16.3 | 364 (73.4) | 117 (23.6) | 15 (3.0) | 0.14 | |
| rs1800625 | 496 | 14.7 | 12.2 | 365 (73.6) | 116 (23.4) | 15 (3.0) | 0.128 | |
| 63bp ins/del | 232 | 6.3 | 203 (87.5) | 29 (12.5) | 0 (0) | 0.31 | ||
| rs2070600 | 232 | 27.4 | 28.9 | 126 (54.3) | 85 (36.6) | 21 (9.1) | 0.23 | |
| rs1800624 | 232 | 11.6 | 16.3 | 181 (78.0) | 48 (20.7) | 3 (1.3) | 0.93 | |
| rs1800625 | 232 | 15.9 | 12.2 | 163 (70.3) | 64 (27.6) | 5 (2.2) | 0.66 | |
Clinical relevance of four variants among trauma patients
| Polymorphic sites | Genotypes | N | Age (yr) | Sex (M/F) | ISS | Sepsis, n/% | MOD score | |
|---|---|---|---|---|---|---|---|---|
| ins/ins | 423 | 40.2 ± 14.6 | 334/89 | 22.3 ± 10.5 | 178 (42.1) | 6.4 ± 2.4 | ||
| 63 bp ins/del | ins/del | 70 | 40.9 ± 11.1 | 59/11 | 20.5 ± 10.5 | 23 (32.9) | 6.1 ± 2.8 | |
| del/del | 3 | 47.3 ± 18.8 | 2/1 | 24.3 ± 8.5 | 1 (33.3) | 6.0 ± 1.7 | ||
| GG | 247 | 39.5 ± 14.4 | 198/49 | 22.2 ± 11.4 | 100 (40.5) | 6.7 ± 2.6 | ||
| rs2070600 | GA | 206 | 41.0 ± 14.4 | 161/45 | 21.9 ± 9.4 | 84 (40.8) | 6.1 ± 2.3 | |
| AA | 43 | 42.5 ± 11.5 | 36/7 | 22.0 ± 10.4 | 18 (41.9) | 5.7 ± 1.6 | ||
| TT | 364 | 40.4 ± 14.3 | 291/73 | 22.2 ± 10.4 | 148 (40.7) | 6.3 ± 2.4 | ||
| rs1800624 | TA | 117 | 40.5 ± 14.3 | 91/26 | 21.7 ± 11.0 | 51 (43.6) | 6.5 ± 2.5 | |
| AA | 15 | 39.7 ± 12.0 | 13/2 | 20.2 ± 8.8 | 3 (20.0) | 7.0 ± 2.6 | ||
| TT | 365 | 40.0 ± 14.1 | 291/74 | 22.4 ± 10.5 | 163 (44.7) | 6.9 ± 2.4 | ||
| rs1800625 | TC | 116 | 42.4 ± 14.4 | 89/27 | 21.3 ± 10.7 | 35 (30.2) | 6.0 ± 2.2 | |
| CC | 15 | 37.3 ± 9.9 | 15/0 | 17.2 ± 9.8 | 4 (26.7) | 5.3 ± 1.5 | ||
| a1 | a2, b1, c1 | |||||||
| ins/ins | 203 | 41.0 ± 12.9 | 165/38 | 23.3 ± 8.6 | 74 (36.4) | 6.9 ± 3.4 | ||
| 63bp ins/del | ins/del | 29 | 41.1 ± 14.9 | 25/4 | 22.7 ± 9.3 | 14 (48.3) | 8.4 ± 3.0 | |
| del/del | 0 | - | - | - | 0 (0) | - | ||
| GG | 126 | 41.3 ± 13.4 | 102/24 | 22.7 ± 8.6 | 48 (38.1) | 7.1 ± 3.1 | ||
| rs2070600 | GA | 85 | 40.7 ± 12.4 | 70/15 | 23.0 ± 8.5 | 35 (41.2) | 6.9 ± 3.6 | |
| AA | 21 | 40.6 ± 14.5 | 18/3 | 27.5 ± 8.6 | 5 (23.8) | 6.9 ± 2.8 | ||
| rs1800624 | TT | 181 | 41.0 ± 13.3 | 150/31 | 23.4 ± 8.7 | 70 (38.7.) | 7.0 ± 3.5 | |
| TA | 48 | 40.6 ± 13.0 | 38/10 | 22.4 ± 8.3 | 16 (33.3) | 7.4 ± 3.2 | ||
| AA | 3 | 44.7 ± 7.1 | 2/1 | 28.0 ± 14.1 | 2 (67.7) | 6.7 ± 2.3 | ||
| TT | 163 | 41.4 ± 13.2 | 138/25 | 23.7 ± 8.5 | 70 (42.9) | 7.3 ± 3.3 | ||
| rs1800625 | TC | 64 | 40.9 ± 13.2 | 47/17 | 21.8 ± 8.6 | 16 (25.0) | 6.9 ± 3.2 | |
| CC | 5 | 37.7 ± 15.7 | 4/1 | 24.3 ± 12.0 | 2 (40.0) | 6.3 ± 2.5 | ||
| a3 | a4, c2 | |||||||
A, dominant effect (variant homozygotes +heterozygotes vs. wild homozygotes) as analyzed by ANOVA, a1P = 0.003, a2P = 0.015, a3P = 0.016, a4P = 0.042; b, recessive effect (variant homozygotes vs. heterozygotes + wild homozygotes); as analyzed by ANOVA, b1P = 0.032; c, Allele Dose Effect as analyzed by linear regression, c1P = 0.045, c2P = 0.048.
Figure 2Effect of the rs1800625 (-429T/C) on LPS-induced TNF-α production. One-way ANOVA was used to assess statistical significance. *P = 0.017 for dominant association (TT + TC vs. TT).
Figure 3Effect of the -429T/C polymorphism on the transcription activity of the . Relative luciferase activity (RLA) was measured in U937 cells transfected with -429T or -429C plasmid constructs as described in methods. The fold increase of RLA was significantly lower in cells transfected with variant C allele than those transfected with wild T allele (P = 0.032).